The quantitative-PCR evaluation of cN-II in three NSCLC cells showed expression levels similar to those detected in tumor specimens, ranging from 1.083 (A549 cells) to 1.056 (H292 cells). The gene discussed is NT5C2; the disease is neoplasm.